Evonik rejects BASF's $12.5B takeover bid but leaves opening for 'purely informational' talks

What happened

Evonik said it will not negotiate with BASF over BASF's €11.2 billion (about $12.5 billion) takeover offer, though it is open to a purely informational and confidential exchange to explain its position.

Confirmed

Global impact / market context

A rejected bid removes a near-term deal path for BASF, which wants scale against global rivals, and leaves Evonik independent for now. Investors in both chemical makers face uncertainty over whether talks resume, which can hold back share prices until direction clears.

Analyst inference

The standoff comes as chemical firms face pressure from Chinese competitors, making consolidation attractive. Evonik is also reportedly exploring a purchase of U.S. chemicals company Ashland, so its capital spending priorities and deal options, not just the BASF bid, shape how investors judge its shares.

Analyst inference

What to watch

1. BASF raised its offer to €24 per share and included extensive commitments on employees and sites, so watch whether Evonik's board treats that package as enough to start formal talks. Confirmed
2. Evonik has offered only a purely informational and confidential exchange, so watch whether that limited contact turns into negotiation or stays one-way with no binding terms discussed. Proposed
3. Evonik is reportedly exploring an Ashland acquisition while weighing other opportunities, so watch whether deal spending on that target competes with or replaces any renewed BASF approach. Analyst inference

Evidence

• seekingalpha.com